- Home
- BLNE vs PHIO Comparison
BLNE vs PHIO Comparison
Compare BLNE & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNE
- PHIO
- Stock Information
- Founded
- BLNE 2019
- PHIO 2011
- Country
- BLNE United States
- PHIO United States
- Employees
- BLNE N/A
- PHIO N/A
- Industry
- BLNE
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- BLNE
- PHIO Health Care
- Exchange
- BLNE NYSE
- PHIO Nasdaq
- Market Cap
- BLNE 11.9M
- PHIO 11.9M
- IPO Year
- BLNE N/A
- PHIO N/A
- Fundamental
- Price
- BLNE $1.56
- PHIO $2.44
- Analyst Decision
- BLNE
- PHIO Strong Buy
- Analyst Count
- BLNE 0
- PHIO 2
- Target Price
- BLNE N/A
- PHIO $9.00
- AVG Volume (30 Days)
- BLNE 5.5M
- PHIO 174.1K
- Earning Date
- BLNE 08-13-2025
- PHIO 08-13-2025
- Dividend Yield
- BLNE N/A
- PHIO N/A
- EPS Growth
- BLNE N/A
- PHIO N/A
- EPS
- BLNE N/A
- PHIO N/A
- Revenue
- BLNE $5,213,000.00
- PHIO N/A
- Revenue This Year
- BLNE $456.73
- PHIO N/A
- Revenue Next Year
- BLNE $28.26
- PHIO N/A
- P/E Ratio
- BLNE N/A
- PHIO N/A
- Revenue Growth
- BLNE 63.03
- PHIO N/A
- 52 Week Low
- BLNE $0.62
- PHIO $0.97
- 52 Week High
- BLNE $29.80
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- BLNE N/A
- PHIO 53.08
- Support Level
- BLNE N/A
- PHIO $2.31
- Resistance Level
- BLNE N/A
- PHIO $2.43
- Average True Range (ATR)
- BLNE 0.00
- PHIO 0.13
- MACD
- BLNE 0.00
- PHIO -0.01
- Stochastic Oscillator
- BLNE 0.00
- PHIO 54.46
About BLNE EASTSIDE DISTILLING INC
Beeline Holdings Inc is a technology-driven mortgage lender and title provider building a fully digital, AI-powered platform that simplifies and accelerates the home financing process.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.